Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Papatheodoridis, ONUR; Dalekos, George; Yurdaydin, Cihan; Buti, Maria; Goulis, John; Arends, Pauline; Sypsa, Vana; Manolakopoulos, Spilios; Mangia, Giampaolo; Gatselis, Nikolaos; KESKİN, ONUR; Savvidou, Savvoula; Hansen, Bettina; Papaioannou, Christos; Galanis, Kostantinos; İDİLMAN, RAMAZAN; Colombo, Massimo; Esteban, Rafael; Janssen, Harry; Lampertico, Pietro

doi:10.1016/j.jhep.2014.08.045

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Atıf İçin Kopyala

Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Buti M., Goulis J., Arends P., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.62, sa.2, ss.363-370, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 62 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.jhep.2014.08.045
Dergi Adı: JOURNAL OF HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.363-370
Hacettepe Üniversitesi Adresli: Hayır

Özet

Background & Aims: The risk of hepatocellular carcinoma (HCC) in Caucasian patients with chronic hepatitis B (CHB), treated with entecavir (ETV) or tenofovir (TDF), is unclear. We evaluated the incidence and predictors of HCC and the accuracy of existing HCC risk scores in Caucasian CHB patients receiving ETV/TDF.